| 26.61 Data as of May 22 |  -0.10 / -0.37%Today’s Change | 15.24 Today|||52-Week Range 31.63 | +2.62% Year-to-Date |
| Previous close | 26.71 |
| Today’s open | 26.86 |
| Day’s range | -- - -- |
| Volume | 504,228 |
| Average volume (3 months) | 515,629 |
| Market cap | $3.0B |
| Dividend yield | -- |
| Earnings growth (last year) | +402.86% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | +34.68% |
| P/E ratio | -- |
| Price/Sales | 9.02 |
| Price/Book | 12.72 |
| Today’s change | Today’s % change | |
|---|---|---|
| AEGRAegerion Pharmaceuti... | -1.77 | -2.95% |
| IMGNImmunogen Inc | -0.17 | -0.99% |
| GEVASynageva Biopharma C... | +0.77 | +1.95% |
| HALOHalozyme Therapeutic... | -0.42 | -5.53% |
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | $0.30 |
| Annual revenue (last year) | $3.4B |
| Annual profit (last year) | $331.6M |
| Net profit margin | 9.79% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Víctor Grifols Roura |
Vice President-Administration & Finance Alfredo Arroyo Guerra |
Corporate headquarters Barcelona, Catalonia |
.
